Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study)

  • Etude concernée: IFCT-0301
  • Auteurs / Authors: Morère JF, Bréchot JM, Westeel V, Gounant V, Lebeau B, Vaylet F, Barlési F, Urban T, Souquet PJ, Debieuvre D, Baudrin L, Zalcman G, Morin F, Milleron B, Moro-Sibilot
  • Journal / Conference: Lung Cancer
  • Année / Year: 2010
  • PMID: 20400201
  • Lien vers la publication: https://www.ncbi.nlm.nih.gov/pubmed/20400201